Wendy future of retail top

Today’s FDA panel meeting could lead to Pfizer getting vaccine emergency use okay

Print Friendly, PDF & Email

WASHINGTON — Commissioner Stephen Hahn said ahead of  today’s meeting of the Food and Drug Administration’s vaccine advisory panel is “an important day for all of America.”

Pfizer’s COVID-19 vaccine faces one last hurdle as it races to become the first shot greenlighted in the U.S. — a panel of experts who will carefully scrutinize the company’s data for any red flags.

Thursday’s meeting of the Food and Drug Administration’s vaccine advisory panel is likely the final step before a U.S. decision to begin shipping millions of doses of the shot, which has shown strong protection against the coronavirus.

Hahn hopes today’s meeting will lead to the beginning of the end of the pandemic and a return “to a more normal and healthy life.”

Hahn said the FDA is also working to understand the allergic reactions that turned up when the United Kingdom began vaccinations this week and that FDA would include recommendations in any emergency use authorization as to who should and should not get the vaccine. Hahn, addressing public skepticism of the vaccine, said if one is authorized, it’s important for people to get vaccinated to arrive at herd immunity.

He added “I have 100% confidence, and I think the American public should as well, with respect to our review of the safety and efficacy of vaccine.”


ECRM_06-01-22


Comments are closed.

Centrum 7/6  banner